Conference abstract
Conference abstractPublished 20 Jun 2016
Next generation targeted recombinant human cytolytic fusion proteins
University of Cape Town, South Africa
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Targeted immunotherapeutics, such as antibody drug conjugates (ADCs) or immunotoxins (ITs) represent promising agents for treatment of cancer. Despite their encouraging performance in clinical trials, both ADCs and ITs suffer from disadvantages like stoichiometrically undefined chemical linkage of the cytotoxic payload and potential immunogenicity of bacteria or plant derived toxins in humans, respectively. Therefore, we designed a number of targeted recombinant cytolytic fusion proteins, replacing bacterial toxins like Pseudomonas exotoxin A by human enzymes/protein derived from proteases, kinases, RNases and microtubule associated proteins. This presentation will summarize the latest results on the next generation of targeted fully human recombinant cytolytic fusion proteins.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 25 Mar 2016
Heat Shock Proteins: An Important Targets for Development of Next Generation Cancer Drugs
Conference abstract
Recombinant fusion constructs of cell-penetrating peptides for targeted drug delivery to mildly acidic environment in solid tumors
Conference abstract
Recombinant proinsulin-transferrin fusion protein A novel insulin analog with sustained and liver-selective hypoglycemic activity
Short communication · 30 Sep 2020
A Novel Recombinant Fusion Protein with Soluble PD-1 and TIM-3 Domains Effectively Binds to Cancer Cells
More from this journal
The newest in Journal of Pharmaceutical Care & Health Systems.
Review article · 9 Jun 2025
Blood Fluid: The Unseen Currents That Bind Life and Death Together
Research article · 8 Jun 2025
Formulation and Antibacterial Evaluation of Acmella olaracea (Akarkara) Gummies Used for Toothache
Research article · 9 Apr 2025
Deep Vein Thrombosis: A Closer Look at a Silent Threat
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Care & Health Systems
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Stefan Barth”

